PMD Device Solutions AB
Company Profile
Business description
PMD Device Solutions AB develops and sells medical products for respiratory monitoring in both the hospital and homecare setting. Its primary product is RespiraSense, a solution used for monitoring respiratory rate to detect deterioration of a patient’s general condition early and to avoid preventable respiratory failure and adverse patient outcomes. RespiraSense is, to the Company’s knowledge, the world’s only continuous, motion-tolerant respiratory rate monitor delivering class-leading reliability in measuring respiratory rate. RespiraSense is a novel technology that is commercialised in Europe, the UK, and FDA-cleared in the US.
Contact
C/o Eversheds Sutherland Advokatbyra AB
Box 14055
Stockholm104 40
SWET: +46 812454859
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2025
Employees
29
Stocks News & Analysis
stocks
10 of the cheapest global companies with wide moats
stocks
Bookworm: Buy and hold inspiration from an unlikely source
stocks
3 ASX shares to avoid
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 8,082.10 | 68.80 | 0.86% |
CAC 40 | 8,062.21 | 33.93 | 0.42% |
DAX 40 | 23,118.15 | 131.33 | 0.57% |
Dow JONES (US) | 41,621.36 | 133.17 | 0.32% |
FTSE 100 | 8,675.95 | 43.62 | 0.51% |
HKSE | 24,145.57 | 185.59 | 0.77% |
NASDAQ | 17,777.37 | 23.29 | 0.13% |
Nikkei 225 | 37,396.52 | 343.42 | 0.93% |
NZX 50 Index | 12,166.14 | 100.11 | -0.82% |
S&P 500 | 5,660.34 | 21.40 | 0.38% |
S&P/ASX 200 | 7,854.10 | 64.40 | 0.83% |
SSE Composite Index | 3,426.13 | 6.57 | 0.19% |